Milestone Scientific Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $33.3M
- Price
- $0.3671
- % Change (Daily % change from the live per-ticker quote feed.)
- +1.41%
- Volume
- 108.8K
About
Milestone Scientific Inc. is dedicated to the innovation, refinement, and global distribution of advanced diagnostic and therapeutic injection technologies and devices. These solutions cater to the medical, dental, and cosmetic industries, with a presence in the United States, China, and other international markets. The company's operations are divided into two main segments: Dental and Medical. Within its Dental division, key products include CompuDent and the STA Single Tooth Anesthesia System, both instrumental for delivering local anesthetics across all dental procedures. For broader applications, the firm offers CompuFlo, a sophisticated computer-controlled system capable of delivering drugs, anesthetics, and other medicaments comfortably and precisely, as well as aspirating bodily fluids or prior injections. Complementing this, a disposable injection handpiece provides precise tactile control during administration. In the Medical segment, Milestone Scientific introduces the CompuFlo Epidural, a computer-guided anesthesia system designed for a variety of medical applications. Additionally, their CompuMed system is utilized in numerous specialized procedures, including plastic surgery, hair restoration, colorectal surgery, podiatry, dermatology, and orthopedics, among others. Headquartered in Livingston, New Jersey, Milestone Scientific Inc. was established in 1989.
Quick stats
Shares outstanding90.6M
Computed float75.3M
Float / shares83.1%
Cash runway (months)7.4
Key info
SectorHealthcare
IndustryMedical - Instruments & Supplies
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0000855683
AI Summary
AI-generated1/15
minorbullishoperations update
Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business
Milestone Scientific highlighted progress building a scalable growth platform for its CompuFlo medical business, centered on physician adoption, reimbursement and recurring disposable revenue.
Through September 2026 the CompuFlo Advisor Program generated over 180 epidural feedback submissions, building on a 145-procedure evaluation in which 99.3% of respondents found the technology easy to use; providers currently receive approximately $325 per procedure in Medicare payment under CPT 0777T in Novitas and First Coast jurisdictions.
Clinical evidence continues to accumulate, including a 79-patient UTMB study associating CompuFlo-guided epidural access with roughly a 91% reduction in adjusted odds of composite complications.
The company has also expanded its commercial organization to three dedicated sales professionals, about 15 consultants and three distribution partners, with international market development underway in Italy, Chile and Qatar and a long-term goal of moving CPT 0777T from Category III to Category I.
Red flags
- No quantified revenue or financial results disclosed; update is qualitative
- Category I CPT designation and reimbursement expansion are not guaranteed per the safe harbor statement
- Small commercial footprint (3 dedicated sales professionals) relative to stated ambitions